Ikarian Capital
Latest statistics and disclosures from Ikarian Capital's latest quarterly 13F-HR filing:
- Top 5 stock holdings are SRPT, BIIB, MRNA, XBI, HZNP, and represent 36.38% of Ikarian Capital's stock portfolio.
- Added to shares of these 10 stocks: BIIB (+$146M), SRPT (+$126M), HZNP (+$62M), ARGX (+$59M), MRNA (+$44M), ARKG (+$41M), BNTX (+$26M), BGNE (+$25M), CCXI (+$22M), CVAC (+$21M).
- Started 74 new stock positions in LSAQ, BLCM, NBIX, AGIO, ACRS, ALBO, INMB, BLSA, ARCT, Longview Acquisition Corp.
- Reduced shares in these 10 stocks: MRTX (-$117M), IGMS (-$28M), CYTK (-$24M), , BCLI (-$20M), ARNA (-$17M), OCUL (-$15M), KOD (-$15M), MDGL (-$13M), MCRB (-$13M).
- Sold out of its positions in ADMA, Aimmune Therapeutics, AL, APLS, APTX, ATRA, AVRO, BCLI, CRNX, DRNA.
- Ikarian Capital was a net buyer of stock by $651M.
- Ikarian Capital has $2.3B in assets under management (AUM), dropping by 64.14%.
- Central Index Key (CIK): 0001778253
Tip: Access up to 7 years of quarterly data
Positions held by Ikarian Capital consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Ikarian Capital
Companies in the Ikarian Capital portfolio as of the December 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Sarepta Therapeutics Put Option (SRPT) | 10.3 | $234M | +116% | 1.4M | 170.49 | |
| Biogen Idec Put Option (BIIB) | 9.0 | $205M | +245% | 836k | 244.86 | |
| Moderna Put Option (MRNA) | 7.0 | $158M | +38% | 1.5M | 104.47 | |
| Spdr Ser Tr S&p Biotech Put Option (XBI) | 6.1 | $138M | +15% | 978k | 140.78 | |
| Horizon Therapeutics Pub L SHS Call Option (HZNP) | 4.0 | $91M | +219% | 1.2M | 73.15 | |
| Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY) | 4.0 | $90M | +20% | 240k | 373.88 | |
| Argenx Se Sponsored Adr Put Option (ARGX) | 2.6 | $59M | +25087% | 202k | 294.09 | |
| Zymeworks Put Option (ZYME) | 2.0 | $45M | +28% | 957k | 47.26 | |
| Ark Etf Tr Genomic Rev Etf Put Option (ARKG) | 1.8 | $41M | NEW | 440k | 93.26 | |
| Novavax Com New (NVAX) | 1.6 | $36M | -13% | 326k | 111.53 | |
| Tracon Pharmaceuticals Com New (TCON) | 1.4 | $32M | +25% | 2.7M | 11.70 | |
| Celldex Therapeutics Com New Call Option (CLDX) | 1.4 | $31M | +15% | 1.8M | 17.52 | |
| Arvinas Ord Put Option (ARVN) | 1.3 | $29M | +110% | 337k | 84.93 | |
| Chemocentryx Put Option (CCXI) | 1.2 | $28M | +351% | 452k | 61.92 | |
Setup an alertIkarian Capital will file the next quarterly 13-HR in about 1 months. Would you like to be notified? |
||||||
| Biontech Se Sponsored Ads Put Option (BNTX) | 1.1 | $26M | NEW | 320k | 81.53 | |
| Beigene Sponsored Adr Put Option (BGNE) | 1.1 | $25M | NEW | 97k | 258.39 | |
| Ascendis Pharma A/s Sponsored Adr Call Option (ASND) | 1.0 | $23M | -4% | 138k | 166.78 | |
| Kalvista Pharmaceuticals Call Option (KALV) | 1.0 | $23M | -2% | 1.2M | 18.98 | |
| Igm Biosciences Put Option (IGMS) | 1.0 | $22M | -55% | 250k | 88.29 | |
| Curevac N V Put Option (CVAC) | 0.9 | $21M | NEW | 261k | 81.07 | |
| Zogenix Com New (ZGNX) | 0.9 | $21M | -3% | 1.0M | 19.99 | |
| Ocular Therapeutix (OCUL) | 0.9 | $21M | -41% | 997k | 20.70 | |
| Reata Pharmaceuticals Cl A Put Option (RETA) | 0.9 | $21M | -4% | 167k | 123.63 | |
| Fibrogen Put Option (FGEN) | 0.9 | $21M | +37% | 552k | 37.09 | |
| Biohaven Pharmaceutical Holding Call Option (BHVN) | 0.8 | $19M | NEW | 223k | 85.71 | |
| Beam Therapeutics Put Option (BEAM) | 0.8 | $19M | NEW | 231k | 81.64 | |
| Bristol Myers Squibb (BMY) | 0.8 | $18M | -27% | 288k | 62.03 | |
| Crispr Therapeutics Namen Akt Put Option (CRSP) | 0.8 | $18M | 115k | 153.11 | ||
| Astrazeneca Sponsored Adr Call Option (AZN) | 0.8 | $18M | NEW | 350k | 49.99 | |
| Gilead Sciences Call Option (GILD) | 0.8 | $18M | NEW | 300k | 58.26 | |
| Morphic Hldg (MORF) | 0.8 | $17M | NEW | 517k | 33.55 | |
| Curis Com New Call Option (CRIS) | 0.8 | $17M | NEW | 2.1M | 8.19 | |
| Eli Lilly & Co. Call Option (LLY) | 0.7 | $17M | NEW | 100k | 168.84 | |
| Ionis Pharmaceuticals Call Option (IONS) | 0.7 | $16M | NEW | 290k | 56.54 | |
| Protara Therapeutics Com Stk (TARA) | 0.7 | $16M | -10% | 650k | 24.21 | |
| Arrowhead Pharmaceuticals Put Option (ARWR) | 0.7 | $15M | +33% | 200k | 76.73 | |
| Prothena Corp SHS (PRTA) | 0.6 | $14M | NEW | 1.2M | 12.01 | |
| Cryoport Com Par $0.001 Call Option (CYRX) | 0.6 | $14M | -38% | 323k | 43.88 | |
| Intra Cellular Therapies (ITCI) | 0.6 | $14M | -25% | 439k | 31.79 | |
| Gossamer Bio (GOSS) | 0.6 | $14M | +115% | 1.4M | 9.67 | |
| Blueprint Medicines Put Option (BPMC) | 0.6 | $14M | NEW | 120k | 112.14 | |
| Sutro Biopharma (STRO) | 0.6 | $13M | +26% | 615k | 21.71 | |
| Acceleron Pharma Put Option (XLRN) | 0.6 | $13M | NEW | 100k | 127.93 | |
| Sage Therapeutics Call Option (SAGE) | 0.6 | $13M | -24% | 148k | 86.52 | |
| Milestone Pharmaceuticals (MIST) | 0.5 | $12M | +5% | 1.8M | 6.70 | |
| Karuna Therapeutics Ord Call Option (KRTX) | 0.5 | $12M | NEW | 120k | 101.60 | |
| Mirati Therapeutics Call Option (MRTX) | 0.5 | $12M | -90% | 54k | 219.62 | |
| Vincera Pharma (VINC) | 0.5 | $11M | NEW | 539k | 20.91 | |
| Immunovant (IMVT) | 0.5 | $11M | -26% | 236k | 46.19 | |
| United Therapeutics Corporation Call Option (UTHR) | 0.5 | $11M | NEW | 69k | 151.80 | |
| Compass Pathways Sponsored Ads (CMPS) | 0.4 | $10M | +38% | 211k | 47.66 | |
| Kura Oncology Call Option (KURA) | 0.4 | $9.7M | +31% | 296k | 32.66 | |
| Black Diamond Therapeutics (BDTX) | 0.4 | $9.4M | -18% | 294k | 32.05 | |
| Merus N V (MRUS) | 0.4 | $9.4M | NEW | 537k | 17.53 | |
| Lyra Therapeutics (LYRA) | 0.4 | $9.3M | +110% | 815k | 11.40 | |
| Global Blood Therapeutics In Put Option (GBT) | 0.4 | $8.8M | +9523% | 202k | 43.33 | |
| Cara Therapeutics Call Option (CARA) | 0.4 | $8.7M | +73% | 575k | 15.13 | |
| Vistagen Therapeutics Com New (VTGN) | 0.4 | $8.7M | NEW | 4.5M | 1.94 | |
| Seres Therapeutics Call Option (MCRB) | 0.4 | $8.4M | -60% | 341k | 24.50 | |
| Allakos Call Option (ALLK) | 0.4 | $8.2M | NEW | 59k | 140.00 | |
| Deciphera Pharmaceuticals Call Option (DCPH) | 0.4 | $8.0M | -41% | 140k | 57.06 | |
| Cytokinetics Com New Call Option (CYTK) | 0.3 | $7.8M | -75% | 377k | 20.77 | |
| Scpharmaceuticals (SCPH) | 0.3 | $7.8M | 1.5M | 5.29 | ||
| Cardiff Oncology Put Option (CRDF) | 0.3 | $7.5M | NEW | 418k | 17.99 | |
| Ardelyx (ARDX) | 0.3 | $7.5M | -24% | 1.2M | 6.47 | |
| Vaxcyte (PCVX) | 0.3 | $7.3M | +1613% | 276k | 26.57 | |
| Vir Biotechnology Put Option (VIR) | 0.3 | $7.2M | NEW | 268k | 26.78 | |
| I Mab Sponsored Ads (IMAB) | 0.3 | $7.1M | 150k | 47.15 | ||
| Fate Therapeutics Call Option (FATE) | 0.3 | $7.0M | -22% | 77k | 90.91 | |
| Bioxcel Therapeutics Call Option (BTAI) | 0.3 | $6.9M | 150k | 46.20 | ||
| Immatics SHS (IMTX) | 0.3 | $6.9M | 638k | 10.79 | ||
| Alnylam Pharmaceuticals Put Option (ALNY) | 0.3 | $6.5M | 50k | 129.98 | ||
| Clovis Oncology Call Option (CLVS) | 0.3 | $6.2M | +11% | 1.3M | 4.80 | |
| Anaptysbio Inc Common (ANAB) | 0.3 | $6.1M | +464% | 282k | 21.49 | |
| Tricida (TCDA) | 0.3 | $6.1M | +3603% | 859k | 7.05 | |
| Solid Biosciences (SLDB) | 0.3 | $6.0M | 788k | 7.58 | ||
| Chimerix (CMRX) | 0.3 | $6.0M | -9% | 1.2M | 4.83 | |
| Strongbridge Biopharma Shs Usd (SBBP) | 0.3 | $5.9M | -27% | 2.4M | 2.43 | |
| Cortexyme Call Option (CRTX) | 0.3 | $5.8M | +358% | 211k | 27.71 | |
| Scholar Rock Hldg Corp (SRRK) | 0.3 | $5.7M | NEW | 117k | 48.52 | |
| Agios Pharmaceuticals Call Option (AGIO) | 0.2 | $5.4M | NEW | 125k | 43.33 | |
| Lifesci Acquisition Ii Corp (LSAQ) | 0.2 | $5.4M | NEW | 505k | 10.62 | |
| Syndax Pharmaceuticals Call Option (SNDX) | 0.2 | $5.4M | NEW | 241k | 22.24 | |
| X4 Pharmaceuticals (XFOR) | 0.2 | $5.3M | +14% | 826k | 6.43 | |
| Tg Therapeutics Put Option (TGTX) | 0.2 | $5.2M | NEW | 100k | 52.02 | |
| Applied Therapeutics (APLT) | 0.2 | $5.1M | NEW | 233k | 22.00 | |
| Fulcrum Therapeutics (FULC) | 0.2 | $5.1M | NEW | 438k | 11.71 | |
| Sierra Oncology Com New (SRRA) | 0.2 | $5.1M | 319k | 16.03 | ||
| Oncternal Therapeutics (ONCT) | 0.2 | $5.0M | NEW | 1.0M | 4.90 | |
| C4 Therapeutics Com Stk (CCCC) | 0.2 | $5.0M | NEW | 152k | 33.13 | |
| Verastem (VSTM) | 0.2 | $4.8M | +59% | 2.3M | 2.13 | |
| Bluebird Bio (BLUE) | 0.2 | $4.5M | +164% | 107k | 42.70 | |
| Quidel Corporation Call Option (QDEL) | 0.2 | $4.5M | NEW | 25k | 179.64 | |
| Arcturus Therapeutics Hldg I Put Option (ARCT) | 0.2 | $4.3M | NEW | 100k | 43.38 | |
| Chardan Healthcr Acqstn 2 Unit 99/99/9999 (CHAQ.U) | 0.2 | $4.2M | 400k | 10.59 | ||
| Diamedica Therapeutics Com New (DMAC) | 0.2 | $4.2M | 415k | 10.14 | ||
| Social Cap Hedspia Hldg Co I Com Cl A | 0.2 | $4.2M | NEW | 250k | 16.77 | |
| Kadmon Hldgs (KDMN) | 0.2 | $3.9M | 937k | 4.15 | ||
| Fs Dev Corp Com Cl A | 0.2 | $3.9M | NEW | 350k | 11.00 | |
| Tcr2 Therapeutics Inc cs (TCRR) | 0.2 | $3.8M | NEW | 122k | 30.93 | |
| Inmune Bio Ord (INMB) | 0.2 | $3.7M | NEW | 218k | 17.22 | |
| Casi Pharmaceuticalsinc Com Stk (CASI) | 0.2 | $3.7M | -17% | 1.3M | 2.95 | |
| Passage Bio (PASG) | 0.2 | $3.5M | NEW | 137k | 25.57 | |
| Aclaris Therapeutics Call Option (ACRS) | 0.2 | $3.5M | NEW | 536k | 6.48 | |
| Xenon Pharmaceuticals (XENE) | 0.2 | $3.4M | 223k | 15.38 | ||
| Shattuck Labs (STTK) | 0.2 | $3.4M | NEW | 65k | 52.40 | |
| Phathom Pharmaceuticals (PHAT) | 0.1 | $3.3M | NEW | 100k | 33.21 | |
| Adverum Biotechnologies Call Option (ADVM) | 0.1 | $3.3M | -56% | 304k | 10.84 | |
| Arena Pharmaceuticals Com New Call Option (ARNA) | 0.1 | $3.3M | -83% | 43k | 76.82 | |
| Chiasma (CHMA) | 0.1 | $3.2M | -55% | 730k | 4.35 | |
| Cyclacel Pharmaceuticals (CYCC) | 0.1 | $3.1M | NEW | 392k | 7.81 | |
| Frequency Therapeutics Put Option (FREQ) | 0.1 | $3.0M | NEW | 86k | 35.25 | |
| Agenus Com New (AGEN) | 0.1 | $3.0M | 950k | 3.18 | ||
| ACADIA Pharmaceuticals (ACAD) | 0.1 | $3.0M | -64% | 56k | 53.47 | |
| Trillium Therapeutics Com New Call Option (TRIL) | 0.1 | $2.9M | NEW | 200k | 14.71 | |
| Mersana Therapeutics (MRSN) | 0.1 | $2.8M | NEW | 106k | 26.60 | |
| Liquidia Corporation Com New (LQDA) | 0.1 | $2.8M | NEW | 951k | 2.95 | |
| Poseida Therapeutics I (PSTX) | 0.1 | $2.8M | +10% | 251k | 10.97 | |
| Madrigal Pharmaceuticals (MDGL) | 0.1 | $2.6M | -82% | 24k | 111.19 | |
| Icad Com New (ICAD) | 0.1 | $2.6M | +7% | 195k | 13.20 | |
| Nektar Therapeutics Call Option (NKTR) | 0.1 | $2.6M | 150k | 17.00 | ||
| Adicet Bio (ACET) | 0.1 | $2.4M | -36% | 174k | 14.05 | |
| Panacea Acquisition Corp Cl A | 0.1 | $2.4M | NEW | 202k | 11.70 | |
| Achieve Life Sciences (ACHV) | 0.1 | $2.3M | 284k | 8.10 | ||
| Neurocrine Biosciences Call Option (NBIX) | 0.1 | $2.3M | NEW | 24k | 95.86 | |
| Yumanity Therapeutics (YMTX) | 0.1 | $2.3M | NEW | 133k | 17.00 | |
| Applied Genetic Technol Corp C (AGTC) | 0.1 | $2.2M | 546k | 4.09 | ||
| Gw Pharmaceuticals Ads Put Option (GWPH) | 0.1 | $2.2M | NEW | 19k | 115.39 | |
| Nextcure (NXTC) | 0.1 | $2.2M | 200k | 10.89 | ||
| Harrow Health (HROW) | 0.1 | $2.1M | -32% | 309k | 6.86 | |
| Delcath Sys Com New (DCTH) | 0.1 | $2.0M | +19% | 113k | 17.91 | |
| Mustang Bio (MBIO) | 0.1 | $2.0M | -34% | 526k | 3.79 | |
| Dbv Technologies S A Sponsored Adr (DBVT) | 0.1 | $1.9M | +117% | 358k | 5.29 | |
| Kiniksa Pharmaceuticals Com Cl A (KNSA) | 0.1 | $1.8M | -70% | 101k | 17.67 | |
| Bellicum Pharmaceuticals Com New (BLCM) | 0.1 | $1.8M | NEW | 500k | 3.53 | |
| Bctg Acquisition Corp (BCTG) | 0.1 | $1.7M | +59704% | 150k | 11.44 | |
| Otonomy (OTIC) | 0.1 | $1.7M | -40% | 259k | 6.47 | |
| Puma Biotechnology (PBYI) | 0.1 | $1.6M | +182% | 155k | 10.25 | |
| Atyr Pharma Com New (LIFE) | 0.1 | $1.6M | NEW | 400k | 3.88 | |
| Catabasis Pharmaceuticals In Com New (CATB) | 0.1 | $1.4M | NEW | 650k | 2.14 | |
| Aurinia Pharmaceuticals Call Option (AUPH) | 0.1 | $1.4M | 100k | 13.83 | ||
| Gamida Cell SHS (GMDA) | 0.1 | $1.3M | NEW | 160k | 8.39 | |
| Longview Acquisition Corp Com Cl A | 0.1 | $1.2M | NEW | 63k | 19.79 | |
| Rigel Pharmaceuticals Com New (RIGL) | 0.1 | $1.2M | -50% | 346k | 3.50 | |
| Homology Medicines Put Option (FIXX) | 0.0 | $1.1M | NEW | 100k | 11.29 | |
| Syros Pharmaceuticals (SYRS) | 0.0 | $1.1M | NEW | 100k | 10.85 | |
| Chembio Diagnostics Com New (CEMI) | 0.0 | $1.0M | NEW | 219k | 4.75 | |
| Alector (ALEC) | 0.0 | $870k | +17812% | 58k | 15.13 | |
| Altimmune Com New (ALT) | 0.0 | $851k | -33% | 75k | 11.28 | |
| 89bio (ETNB) | 0.0 | $799k | -90% | 33k | 24.36 | |
| Inflarx Nv (IFRX) | 0.0 | $754k | 150k | 5.04 | ||
| Albireo Pharma (ALBO) | 0.0 | $633k | NEW | 17k | 37.49 | |
| Kala Pharmaceuticals (KALA) | 0.0 | $594k | -80% | 88k | 6.76 | |
| Cerecor (CERC) | 0.0 | $536k | 203k | 2.64 | ||
| Arcus Biosciences Incorporated Put Option (RCUS) | 0.0 | $532k | NEW | 21k | 25.95 | |
| Cogent Biosciences (COGT) | 0.0 | $469k | NEW | 42k | 11.23 | |
| Aerpio Pharmaceuticals (ARPO) | 0.0 | $468k | -87% | 476k | 0.98 | |
| Bristol-myers Squibb Right 99/99/9999 | 0.0 | $444k | -64% | 644k | 0.69 | |
| Assembly Biosciences (ASMB) | 0.0 | $439k | -53% | 73k | 6.06 | |
| Mereo Biopharma Group Ads (MREO) | 0.0 | $416k | -4% | 1.1M | 0.36 | |
| Arbutus Biopharma (ABUS) | 0.0 | $408k | 115k | 3.55 | ||
| Aslan Pharmaceuticals Ads (ASLN) | 0.0 | $405k | NEW | 2.0M | 0.20 | |
| Sunesis Pharmaceuticals Com New | 0.0 | $398k | NEW | 200k | 1.99 | |
| Rapt Therapeutics Call Option (RAPT) | 0.0 | $377k | -8% | 19k | 19.71 | |
| Avadel Pharmaceuticals Sponsored Adr (AVDL) | 0.0 | $366k | 55k | 6.69 | ||
| Bellus Health Com New (BLU) | 0.0 | $306k | 100k | 3.06 | ||
| Millendo Therapeutics (MLND) | 0.0 | $289k | 135k | 2.14 | ||
| Praxis Precision Medicines I (PRAX) | 0.0 | $275k | NEW | 5.0k | 55.00 | |
| Inhibrx (INBX) | 0.0 | $266k | NEW | 8.1k | 32.94 | |
| Soleno Therapeutics Com New (SLNO) | 0.0 | $236k | NEW | 123k | 1.93 | |
| Inventiva Sa Ads (IVA) | 0.0 | $214k | 15k | 14.27 | ||
| Corbus Pharmaceuticals Hldgs (CRBP) | 0.0 | $174k | -36% | 139k | 1.25 | |
| Eyepoint Pharmaceuticals Com New Call Option (EYPT) | 0.0 | $119k | NEW | 18k | 6.65 | |
| Baudax Bio (BXRX) | 0.0 | $101k | 100k | 1.01 | ||
| Kinnate Biopharma (KNTE) | 0.0 | $79k | NEW | 2.0k | 39.50 | |
| Rocket Pharmaceuticals (RCKT) | 0.0 | $75k | NEW | 1.4k | 53.57 | |
| Translate Bio Put Option (TBIO) | 0.0 | $67k | NEW | 3.6k | 18.61 | |
| Alpine Immune Sciences (ALPN) | 0.0 | $60k | 4.7k | 12.66 | ||
| Stealth Biotherapeutics Corp Sponsored Ads (MITO) | 0.0 | $57k | 38k | 1.52 | ||
| Aptose Biosciences Com New (APTO) | 0.0 | $18k | 3.9k | 4.61 | ||
| Karyopharm Therapeutics (KPTI) | 0.0 | $12k | NEW | 791.00 | 15.17 | |
| Compugen Ord Put Option (CGEN) | 0.0 | $6.0k | NEW | 500.00 | 12.00 | |
| Bcls Acquisition Corp Com Cl A (BLSA) | 0.0 | $1.0k | NEW | 100.00 | 10.00 | |
Past Filings by Ikarian Capital
SEC 13F filings are viewable for Ikarian Capital going back to 2019
- Ikarian Capital 2020 Q4 filed Feb. 12, 2021
- Ikarian Capital 2020 Q3 filed Nov. 16, 2020
- Ikarian Capital 2020 Q2 filed Aug. 14, 2020
- Ikarian Capital 2020 Q1 filed May 15, 2020
- Ikarian Capital 2019 Q4 filed Jan. 31, 2020